Akribion Genomics: Funding, Investors & Team (Sep 2026)
Akribion Genomics utilizes CRISPR nuclease technology to create gene-editing tools and treatments for cancer.
Akribion Genomics has raised $8.3M across 1 funding round on record, the most recent a Seed of $8.3M announced in Feb 2025.
That round is in line with the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Akribion Genomics Company Profile and Key Stats
Latest funding round on record: Feb 2025.
Akribion Genomics Funding Rounds
Akribion Genomics Founders and Leadership Team
Contact details for the Akribion Genomics team: 1 of 1 has an email address on file.
Start 14-day free trial →Akribion Genomics Funding Compared to Other Biotechnology Startups
Akribion Genomics' latest round of $8.3M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Akribion Genomics in Biotechnology and Zwingenberg
Companies Similar to Akribion Genomics
Computomics applies AI to bioinformatics data to enable rapid understanding of genomics and drive advanced…
smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug…
Pacifico Biolabs offers fermentation biotechnology for development, production and distribution of…
NanoStruct is a biotechnology company that develops nanostructured sensor chips to identify bacteria and…
Tacalyx, a company originating from Max-Planck-Institute of Colloids and Interfaces in Potsdam, Germany, is…
Primogene is a biotechnology company that provides ingredient development, bioprocess manufacturing, and…
Mbiomics is a company in the field of biotechnology.
At EVANIUM, we make plant compounds like polyphenols and flavonoids more effective by improving their…
Picea Biosolutions is a biotechnology firm. Based on their core platform technology, they develop tailored…
KUPANDO is a pioneering biopharmaceutical firm that is developing TLR 4/7 agonists to boost innate immunity.…
Akribion Genomics Funding FAQs
What does Akribion Genomics do?
Akribion Genomics utilizes CRISPR nuclease technology to create gene-editing tools and treatments for cancer.
How much funding has Akribion Genomics raised?
Akribion Genomics has raised $8.3M across 1 round on record. The most recent is a Seed of $8.3M announced in Feb 2025.
When did Akribion Genomics last raise funding?
Akribion Genomics' most recent funding round on record is a Seed of $8.3M, announced in Feb 2025.
Who founded Akribion Genomics?
FundedIQ lists Lukas Linnig (Founder) at Akribion Genomics.
Where is Akribion Genomics headquartered?
Akribion Genomics is based in Zwingenberg, Hessen, Germany.
How many employees does Akribion Genomics have?
Akribion Genomics is in the 11-50 employee band.
How does Akribion Genomics' funding compare to other Biotechnology startups?
Akribion Genomics' latest round of $8.3M is in line with the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Akribion Genomics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Akribion Genomics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.